Company intelligence / Profile preview
Gen Y Biologics
Singapore, Singaporegenybiologics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Gen Y Biologics was a Singapore-based biotechnology company and a spin-off from the National University of Singapore (NUS). Founded in 2020 by Associate Professor Paul MacAry, the company focused on the discovery and development of human monoclonal antibodies for the diagnosis and treatment of infectious diseases, with a primary focus on Dengue fever and COVID-19. In collaboration with NUS, Gen Y Biologics commercialized the ImTracker MULTI COVID-19 viral variant neutralization test, a lateral flow immunoassay designed to detect neutralizing antibodies. The company also worked on therapeutic antibody candidates targeting the Dengue virus envelope protein. Gen Y Biologics was officially struck off the Singapore register of companies in January 2026.
- Therapeutic areas
- Infectious Diseases
- Modalities
- AntibodyBiologicDevice
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
National University of Singapore
Beyond the preview
Go deeper on Gen Y Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gen Y Biologics.